Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Vaccine ; 16(7): 685-91, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9562687

ABSTRACT

Poly(D,L-lactide-co-glycolide) microspheres loaded with phosphorylcholine linked to thyroglobulin (PC-Thyr) as protein carrier were prepared. The entrapment efficiency reached 80% when the initial protein:polymer ratio was 1:8. Ninety-four percent of the loaded microspheres had a diameter < or = 10 microns. The encapsulation process did not alter PC-Thyr absorbance nor PC antigenic reactivity. Oral administration of these microspheres induced a specific IgA response in intestinal, pulmonary and vaginal secretions, as well as a strong specific systemic immune response in female Balb/c mice. This suggests the need to explore further the potential ability of PC-Thyr loaded microspheres to protect against infections caused by PC-bearing microorganisms which invade or colonize different mucosal sites.


Subject(s)
Immunity, Mucosal/drug effects , Immunity, Mucosal/immunology , Lactic Acid/administration & dosage , Phosphorylcholine/administration & dosage , Phosphorylcholine/immunology , Polyglycolic Acid/administration & dosage , Polymers/administration & dosage , Vaccines/administration & dosage , Administration, Oral , Animals , Biocompatible Materials/administration & dosage , Drug Delivery Systems , Female , Mice , Mice, Inbred BALB C , Microspheres , Polylactic Acid-Polyglycolic Acid Copolymer , Thyroglobulin/administration & dosage , Thyroglobulin/immunology
2.
Infect Immun ; 65(3): 853-7, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9038287

ABSTRACT

Encapsulation of vaccines in biodegradable microspheres provides excellent mucosal immunogens with a high potential for immunization against bacterial infections. We tested the protective immunity elicited by intragastric vaccination with phosphorylcholine (PC) encapsulated in poly(DL-lactide-co-glycolide) (DL-PLG) microspheres against Salmonella typhimurium in a mouse model of invasive intestinal infection. We chose PC as the antigen because it was found to elicit an immune response after intestinal exposure of mice to PC-bearing S. typhimurium and because anti-PC immunity protects mice against Streptococcus pneumoniae, another PC-bearing microorganism. Mice were primed intragastrically on days 1, 2, and 3 and boosted on days 28, 29, and 30 with PC (280 microg) coupled to porcine thyroglobulin (PC-thyr) encapsulated in DL-PLG microspheres, free PC-thyr, or blank microspheres. A significant rise in anti-PC immunoglobulin A (IgA) titers, as measured by an enzyme-linked immunosorbent assay, was observed in the intestinal secretions after immunization with PC-loaded microspheres, compared to the titers of mice immunized with free PC-thyr or blank microspheres. This antibody response peaked 14 days after the last boost and correlated with a highly significant resistance to oral challenge by S. typhimurium C5 (P < 10(-3)). Control mice were primed intraperitoneally on day 1 with 15 microg of PC in complete Freund's adjuvant and boosted on days 10, 14, and 20 with the same dose without adjuvant but via the same route. In these mice, the levels of anti-PC IgA in intestinal secretions were equivalent to those of the mice intragastrically immunized with PC-loaded microspheres, but protection was significantly weaker, suggesting that either the IgAs were not functional or that other immune mechanisms are important in protection. Taken together, our results highlight the potential of antigen encapsulation in DL-PLG microspheres for eliciting protective immunity against invasive intestinal bacterial diseases and suggest that a similar strategy could be used against diseases caused by other PC-bearing microorganisms.


Subject(s)
Bacterial Vaccines/immunology , Lactic Acid , Phosphorylcholine/immunology , Polyglycolic Acid , Polymers/administration & dosage , Salmonella typhimurium/immunology , Administration, Oral , Animals , Antibodies, Bacterial/analysis , Mice , Microspheres , Phosphorylcholine/administration & dosage , Polylactic Acid-Polyglycolic Acid Copolymer , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL